Login

Office Deal Highlights Boston Biotech's Spread From Cambridge

Healthpeak Pays $333 Million As Investors Hungry for Properties Expand Their Hunting Grounds
The ARC, at 35 Cambridgepark Drive in Boston's Alewife neighborhood, is home to Japanese pharmaceutical giant Eisai and cellular research firm Codiak Biosciences. (CoStar)
The ARC, at 35 Cambridgepark Drive in Boston's Alewife neighborhood, is home to Japanese pharmaceutical giant Eisai and cellular research firm Codiak Biosciences. (CoStar)
By John Doherty
CoStar News
December 11, 2019 | 8:25 P.M.

A California real estate investment trust has plunked down $332.5 million for a year-old office and lab building in Cambridge, Massachusetts, in a deal that illustrates how the surging local biotech industry is slowly spreading out from its traditional neighborhood and changing the area's DNA.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE